PRRT Neuroendocrine Tumor Response monitored using Circulating Transcript Analysis: The NETest

PURPOSE: Peptide receptor radionuclide therapy (PRRT) is effective for metastatic/inoperable neuroendocrine tumors (NETs). Imaging response assessment is usually efficient subsequent to treatment completion. Blood biomarkers such as PRRT Predictive Quotient (PPQ) and NETest are effective in real-tim...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur J Nucl Med Mol Imaging
Autors principals: Bodei, Lisa, Kidd, Mark S., Singh, Aviral, van der Zwan, Wouter A., Severi, Stefano, Drozdov, Ignat A., Malczewska, Anna, Baum, Richard P., Kwekkeboom, Dik J, Paganelli, Giovanni, Krenning, Eric P., Modlin, Irvin M.
Format: Artigo
Idioma:Inglês
Publicat: 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7515632/
https://ncbi.nlm.nih.gov/pubmed/31838581
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-019-04601-3
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars